110578 ⎘
ssDNA viruses; Details; Parvoviridae; Parvovirus, e.g. minute virus of mice New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
cis AND trans REQUIREMENTS FOR TERMINAL RESOLUTION OF HUMAN BOCAVIRUS 1
#2A CHIMERIC HELPER NUCLEIC ACID MOLECULE COMPRISING HELPER ELEMENTS FROM THREE DISTINCT HELPER VIRUSES
#3ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING INCREASED HEART ENRICHMENT
#4BOCAPARVOVIRUS SMALL NONCODING RNA AND USES THEREOF
#5PROTOPARVOVIRUS COMPOSITIONS COMPRISING A PROTOPARVOVIRUS VARIANT VP1 CAPSID POLYPEPTIDE AND RELATED METHODS
#6BACULOVIRUS EXPRESSION SYSTEM
#7Parvovirus structural protein for the treatment of autoimmune diseases
#8Restrictive inverted terminal repeats for viral vectors
#9Novel oncolytic parvoviruses with enhanced cargo capacity, stable shRNA expression cassette and novel immunogenic properties
#10Recombinant canine parvovirus 2a VP2 and 2b VP2 antigen protein, and use thereof
#11small noncoding RNA and uses thereof
#12Restrictive inverted terminal repeats for viral vectors
#13Parvovirus structural protein for the treatment of autoimmune diseases
#14Methods of manufacturing an immunogenic composition comprising a recombinant protein
#15Vaccine against porcine parvovirus
#16Bocaparvovirus small noncoding RNA and uses thereof
#17cis and trans requirements for terminal resolution of human bocavirus 1
#18Restrictive inverted terminal repeats for viral vectors
#19Chimeric adeno-associated virus/ bocavirus parvovirus vector
#20Vaccine antigen with increased immunogenicity
#21Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
#22Vaccine against porcine parvovirus
#23Attenuated parvovirus vaccine for muscovy duck parvovirus and goose parvovirus (derzsy's disease)
#24Porcine parvovirus
#25Dry formulations of vaccines that are room temperature stable
#26Restrictive inverted terminal repeats for viral vectors
#27Chimeric adeno-associated virus/ bocavirus parvovirus vector
#28Porcine parvovirus 5B, methods of use and vaccine
#29Liquid stable virus vaccines
#30Attenuated parvovirus vaccine for Muscovy duck parvovirus and goose parvovirus (Derzsys disease)
#31Polypeptides and vectors for targeting HER2/expressing cells and uses thereof
#32Liquid stable virus vaccines
#33Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsid
#34Live attenuated parvovirus
#35Modified parvovirus having enhanced anti-tumor efficacy
#36Modified rodent parvovirus capable of propagating and spreading through human gliomas
#37COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING A HUMAN PARVOVIRUS INFECTION
#38Isolation of a virus related to canine parvovirus-2 from a raccoon
#39Human bocavirus and methods of diagnosis and treatment
#40Human Parvovirus: Bocavirus
#41HUMAN PARVOVIRUS: HUMINK PARVOVIRUS
#42Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
#43COMPOSITIONS AND PROCESSES RELATING TO HUMAN BOCAVIRUS
#44Polynucleotide encoding a fusion polypeptide suitable as cytotoxin
#45Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis
#46Human parvovirus: bocavirus
#47Chimeric tymovirus-like particles and process thereof
#48Human and methods of diagnosis and treatment
#49USE OF RECOMBINANT ANTIGENS TO DETERMINE THE IMMUNE STATUS OF AN ANIMAL
#50Immunodeficiency recombinant poxvirus
#51Modified plant viruses and methods of use thereof
#52Cell surface expression vector of parvovirus antigen and microorganisms transformed thereof
#53Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
#54Fusion polypeptide suitable as a cytotoxin
#55Recombinant icosahedral virus like particle production in pseudomonads